New York State Common Retirement Fund’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-506
Closed -$248 3423
2023
Q2
$248 Sell
506
-34,200
-99% -$28K ﹤0.01% 3394
2023
Q1
$40.3K Buy
34,706
+89
+0.3% +$163 ﹤0.01% 3034
2022
Q4
$92.8K Sell
34,617
-72
-0.2% -$190 ﹤0.01% 2981
2022
Q3
$99K Buy
34,689
+166
+0.5% +$706 ﹤0.01% 3016
2022
Q2
$172K Sell
34,523
-52
-0.2% -$272 ﹤0.01% 2866
2022
Q1
$246K Sell
34,575
-29
-0.1% -$240 ﹤0.01% 2744
2021
Q4
$629K Sell
34,604
-10,246
-23% -$221K ﹤0.01% 2324
2021
Q3
$877K Sell
44,850
-12,315
-22% -$468K ﹤0.01% 2174
2021
Q2
$2.56M Buy
57,165
+20,027
+54% +$928K ﹤0.01% 1721
2021
Q1
$1.86M Buy
37,138
+14,895
+67% +$1.02M ﹤0.01% 1819
2020
Q4
$1.99M Buy
22,243
+20,299
+1,044% +$1.71M ﹤0.01% 1700
2020
Q3
$148K Buy
+1,944
New +$123K ﹤0.01% 2777

Other funds holding CELL

New York State Common Retirement Fund's CELL Position: Q3 2023 in Review

New York State Common Retirement Fund sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 506 shares — an estimated $248 sold.

New York State Common Retirement Fund first reported a position in CELL in Q3 2020 and held it in 12 quarters. The position peaked at $2.56M in Q2 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • New York State Common Retirement Fund reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 506 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $248.
  • New York State Common Retirement Fund first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • New York State Common Retirement Fund's PhenomeX Inc. Common Stock position peaked at $2.56M in Q2 2021.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.